Literature DB >> 26255043

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.

Lena Böhn1, Stine Störsrud1, Therese Liljebo2, Lena Collin3, Perjohan Lindfors4, Hans Törnblom1, Magnus Simrén5.   

Abstract

BACKGROUND & AIMS: A diet with reduced content of fermentable short-chain carbohydrates (fermentable oligo-, di-, monosaccharides, and polyols [FODMAPs]) has been reported to be effective in the treatment of patients with irritable bowel syndrome (IBS). However, there is no evidence of its superiority to traditional dietary advice for these patients. We compared the effects of a diet low in FODMAPs with traditional dietary advice in a randomized controlled trial of patients with IBS.
METHODS: We performed a multi-center, parallel, single-blind study of 75 patients who met Rome III criteria for IBS and were enrolled at gastroenterology outpatient clinics in Sweden. Subjects were randomly assigned to groups that ate specific diets for 4 weeks-a diet low in FODMAPs (n = 38) or a diet frequently recommended for patients with IBS (ie, a regular meal pattern; avoidance of large meals; and reduced intake of fat, insoluble fibers, caffeine, and gas-producing foods, such as beans, cabbage, and onions), with greater emphasis on how and when to eat rather than on what foods to ingest (n = 37). Symptom severity was assessed using the IBS Symptom Severity Scale, and patients completed a 4-day food diary before and at the end of the intervention.
RESULTS: A total of 67 patients completed the dietary intervention (33 completed the diet low in FODMAPs, 34 completed the traditional IBS diet). The severity of IBS symptoms was reduced in both groups during the intervention (P < .0001 in both groups before vs at the end of the 4-week diet), without a significant difference between the groups (P = .62). At the end of the 4-week diet period, 19 patients (50%) in the low-FODMAP group had reductions in IBS severity scores ≥50 compared with baseline vs 17 patients (46%) in the traditional IBS diet group (P = .72). Food diaries demonstrated good adherence to the dietary advice.
CONCLUSIONS: A diet low in FODMAPs reduces IBS symptoms as well as traditional IBS dietary advice. Combining elements from these 2 strategies might further reduce symptoms of IBS. ClinicalTrials.gov ID NCT02107625.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbohydrates; Colon; Food; Gastrointestinal Symptoms

Mesh:

Substances:

Year:  2015        PMID: 26255043     DOI: 10.1053/j.gastro.2015.07.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  142 in total

1.  Controversies and Recent Developments of the Low-FODMAP Diet.

Authors:  Peta Hill; Jane G Muir; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-01

Review 2.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

3.  Letter: avoid FODMAPs or follow simple tips--authors' reply.

Authors:  B P Chumpitazi; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2015-12       Impact factor: 8.171

4.  Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.

Authors:  C J Tuck; K M Taylor; P R Gibson; J S Barrett; J G Muir
Journal:  Am J Gastroenterol       Date:  2017-08-15       Impact factor: 10.864

Review 5.  Common Functional Gastroenterological Disorders Associated With Abdominal Pain.

Authors:  Adil E Bharucha; Subhankar Chakraborty; Christopher D Sletten
Journal:  Mayo Clin Proc       Date:  2016-08       Impact factor: 7.616

6.  Diet: Food for thought.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2016-05-19       Impact factor: 49.962

Review 7.  Novel perspectives on therapeutic modulation of the gut microbiota.

Authors:  Justin L McCarville; Alberto Caminero; Elena F Verdu
Journal:  Therap Adv Gastroenterol       Date:  2016-04-04       Impact factor: 4.409

Review 8.  Irritable bowel syndrome: a gut microbiota-related disorder?

Authors:  Yogesh Bhattarai; David A Muniz Pedrogo; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

Review 9.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

Review 10.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.